舌根部巨大淋巴瘤1例报告

doi:10.19438/j.cjoms.2026.05.015

中国口腔颌面外科杂志 ›› 2026, Vol. 24 ›› Issue (5): 537-540.doi: 10.19438/j.cjoms.2026.05.015

• 病例报告 • 上一篇

舌根部巨大淋巴瘤1例报告

张奥林, 张永红

河南大学淮河医院口腔科,河南开封 475000

收稿日期:2025-07-30 修回日期:2026-05-18 出版日期:2026-09-20 发布日期:2026-10-10
通讯作者: 张永红,E-mail: kfzhangyonghong@126.com
作者简介:张奥林（1996—）,男,硕士,住院医师,E-mail: orrin369@163.com

Giant lymphoma at the base of the tongue: a case report

Zhang Aolin, Zhang Yonghong

Department of Stomatology, Huaihe Hospital of Henan University. Kaifeng 475000, Henan Province, China

Received:2025-07-30 Revised:2026-05-18 Online:2026-09-20 Published:2026-10-10

摘要/Abstract

摘要： 淋巴瘤是一组异质性淋巴细胞恶性肿瘤,可累及淋巴组织、骨髓或淋巴结部位。发生于舌根部的巨大淋巴瘤因其罕见性及临床表现的多样性,常被误诊为良性肿瘤或感染性疾病。本文报告1例27岁男性舌根部巨大肿物病例,经病理确诊为弥漫大B细胞淋巴瘤。结合相关文献分析其临床病理特征、诊断及治疗要点,以期为临床诊疗工作提供参考。

关键词: 舌根部, 淋巴瘤, 弥漫大B细胞淋巴瘤

Abstract: Lymphoma is a heterogeneous group of malignant tumors of lymphoid cells that can affect lymphoid tissue, bone marrow, or lymph nodes. Giant lymphomas occurring in the base of the tongue are often misdiagnosed as benign tumors or infectious diseases due to their rarity and diverse clinical manifestations. This article reported a case of a giant mass at the base of the tongue in a 27-year-old male, which was pathologically confirmed as diffuse large B-cell lymphoma. By reviewing relevant literature, we analyzed its clinical-pathological characteristics, diagnostic and therapeutic considerations, aiming to provide reference for clinical practice.

Key words: Tongue base, Lymphoma, Diffuse large B-cell lymphoma

中图分类号:

R739.8

张奥林, 张永红. 舌根部巨大淋巴瘤1例报告[J]. 中国口腔颌面外科杂志, 2026, 24(5): 537-540.

Zhang Aolin, Zhang Yonghong. Giant lymphoma at the base of the tongue: a case report[J]. China J Oral Maxillofac Surg, 2026, 24(5): 537-540.

参考文献

[1] 庹吉妤, 张敏, 郑荣寿, 等. 2015 年中国恶性淋巴瘤发病与死亡分析[J]. 中国肿瘤,2021, 30(1): 35-40.
Tuo JY, Zhang M, Zheng RS, et al.Analysis of malignant lymphoma incidence and mortality in China, 2015[J]. China Cancer, 2021, 30(1): 35-40.
[2] Barone S, Buffone C, Ferrillo M, et al.Oral malignant non-Hodgkin lymphoma: a retrospective single-center study[J]. Int J Environ Res Public Health, 2022, 19(5): 2605.
[3] Swerdlow SH, Campo E, Pileri SA, et al.The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J]. Blood, 2016, 127(20): 2375-2390.
[4] Shankland KR, Armitage JO, Hancock BW.Non-Hodgkin lymphoma[J]. Lancet, 2012, 380(9844): 848-857.
[5] Walter C, Ziebart T, Sagheb K, et al.Malignant lymphomas in the head and neck region-a retrospective, single-center study over 41 years[J]. Int J Med Sci, 2015, 12(2): 141-145.
[6] Zapater E, Bagán JV, Carbonell F, et al.Malignant lymphoma of the head and neck[J]. Oral Dis, 2010, 16(2): 119-128.
[7] Hart S, Horsman JM, Radstone CR, et al.Localised extranodal lymphoma of the head and neck: the Sheffield Lymphoma Group experience (1971-2000)[J]. Clin Oncol, 2004, 16(3): 186-192.
[8] Ezzat AA, Ibrahim EM, El Weshi AN, et al.Localized non-Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients[J]. Head Neck, 2001, 23(7): 547-558.
[9] Singh R, Shaik S, Negi BS, et al.Non-Hodgkin's lymphoma: a review[J]. J Fam Med Prim Care, 2020, 9(4): 1834-1840.
[10] Abdelwahed Hussein MR.Non-Hodgkin's lymphoma of the oral cavity and maxillofacial region: a pathologist viewpoint[J]. Expert Rev Hematol, 2018, 11(9): 737-748.
[11] Bhattacharyya I, Chehal HK, Cohen DM, et al.Primary diffuse large B-cell lymphoma of the oral cavity: germinal center classification[J]. Head Neck Pathol, 2010, 4(3): 181-191.
[12] Poeschel V, Held G, Ziepert M, et al.Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial[J]. Lancet, 2019, 394(10216): 2271-2281.
[13] International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma[J]. N Engl J Med, 1993, 329(14): 987-994.
[14] 朱海燕, 李菲, 赵瑜, 等. 组合临床国际预后指数、病理免疫分型及中期PET/CT建立的模型在弥漫大B细胞淋巴瘤预后评估中的应用[J]. 中国医学影像学杂志, 2019, 27(4): 298-301, 308.
[15] Harlendea NJ, Harlendo K.Ki-67 as a marker to differentiate Burkitt lymphoma and diffuse large B-cell lymphoma: a literature review[J]. Cureus, 2024, 16(10): e72190.

舌根部巨大淋巴瘤1例报告

Giant lymphoma at the base of the tongue: a case report

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 8

编辑推荐

Metrics

本文评价

[1]	杨彩秀, 卜令学, 陈立强, 范存晖, 王双义. 颌面部原发性皮肤间变大细胞淋巴瘤1例报告及文献复习[J]. 中国口腔颌面外科杂志, 2021, 19(4): 380-384.
[2]	孙琦, 马超, 董敏俊, 陶晓峰. 感兴趣区大小选择对多形性腺瘤和腺淋巴瘤ADC测量的影响[J]. 中国口腔颌面外科杂志, 2021, 19(1): 29-35.
[3]	原振英, 李明, 管翠强, 闫星泉, 南欣荣. 腮腺T细胞淋巴瘤1例报告及文献复习[J]. 中国口腔颌面外科杂志, 2020, 18(2): 186-189.
[4]	张湉, 吴云腾, 郭伟. 口腔颌面-头颈部黏膜相关淋巴组织边缘区淋巴瘤临床及预后分析[J]. 中国口腔颌面外科杂志, 2019, 17(5): 424-430.
[5]	顾挺，胡宇华，夏荣辉，田臻，王丽珍，张春叶，李江. 免疫组织化学双染技术在唾液腺淋巴上皮性病变中的应用评价[J]. 中国口腔颌面外科杂志, 2019, 17(3): 216-220.
[6]	王盼盼, 王宇帆, 杨宏宇. 颌骨及上颌窦Burkitt淋巴瘤1例报告及文献复习[J]. 中国口腔颌面外科杂志, 2018, 16(4): 382-384.
[7]	彭灿邦, 田臻, 季彤. 头颈部炎性肌纤维母细胞瘤研究进展[J]. 中国口腔颌面外科杂志, 2018, 16(1): 84-88.
[8]	林璐;苏彤. 先后罹患2种不同类型头颈部恶性肿瘤病例报告 [J]. 中国口腔颌面外科杂志, 2013, 11(5): 438-440.